SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-008222
Filing Date
2020-05-11
Accepted
2020-05-11 16:02:42
Documents
68
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 576092
2 ex31-1.htm EX-31.1 12173
3 ex31-2.htm EX-31.2 12270
4 ex32-1.htm EX-32.1 8596
5 logo_001.jpg GRAPHIC 4853
  Complete submission text file 0001493152-20-008222.txt   3216036

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE mtnb-20200331.xml EX-101.INS 513167
7 XBRL SCHEMA FILE mtnb-20200331.xsd EX-101.SCH 56081
8 XBRL CALCULATION FILE mtnb-20200331_cal.xml EX-101.CAL 60782
9 XBRL DEFINITION FILE mtnb-20200331_def.xml EX-101.DEF 105879
10 XBRL LABEL FILE mtnb-20200331_lab.xml EX-101.LAB 324844
11 XBRL PRESENTATION FILE mtnb-20200331_pre.xml EX-101.PRE 212088
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-443-1860
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38022 | Film No.: 20864682
SIC: 2834 Pharmaceutical Preparations